During the second quarter of 2023, there was a 7% increase in patent applications for immuno-oncology compared to the previous quarter, indicating a dynamic transformation in the oncology landscape. Interestingly, along with patent filing, we also saw companies actively acquiring patents in the domain. Thus confirming that it’s not just the number of patent filings that determines the industry’s future; but also the significant investments by companies who scout and acquire novel technologies in the field.
Pfizer, for instance, before acquiring Seagen, strategically obtained various oncology patents to mark their entry into the oncology domain. The example highlights how tracing the patent buyer data can help identify players who aim to move into a new market and can be a great collaborators if you hold patents in the same domain.
Furthermore, this data holds the key to finding the right buyers who recognize the value of your oncology patents, an invaluable resource if scaling isn’t your immediate goal.
Now to aid you in finding potential patent buyers or collaborators, we present the top 10 companies and researchers actively buying IP assets in this domain.
The complete list of oncology patent buyers includes notable names from diverse industries like Samsung, General Atomics, etc. Wish to discover them all?
Simply fill out the form, and we’ll deliver it to your inbox.
Top 10 Companies Buying Oncology Patents
| Name of the Company | Number of Patents bought |
| NOVARTIS | 429 |
| EXACT SCIENCES | 338 |
| AGENSYS | 194 |
| GUARDANT HEALTH | 167 |
| CELGENE | 164 |
| MILLENNIUM PHARMACEUTICALS | 159 |
| EXACT SCIENCES DEVELOPMENT | 153 |
| BIONTECH | 152 |
| PHARMACYCLICS | 144 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 131 |
Top 10 Universities/Research Institutes Buying Oncology Patents
| Name of the Institute | Number of Patents bought |
| NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 4581 |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 878 |
| THE JOHNS HOPKINS UNIVERSITY | 582 |
| MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 552 |
| NATIONAL INSTITUTES OF HEALTH – DIRECTOR DEITR | 540 |
| THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 488 |
| THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 479 |
| THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 413 |
| BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 407 |
| FRED HUTCHINSON CANCER CENTER | 388 |
Whether pursuing the right collaborator or seeking the perfect buyer for your intellectual assets, the journey to finding the right fit can be daunting. You might ponder researching every name on our patent buyers list, a time-consuming and complex process.
But you don’t have to do it alone. GreyB can evaluate the true value of your patent assets and find you the right collaborators.
Click the button below, and connect with our IP Experts to make the most of your oncology patents.
Next Read: How to Increase the Value of Your Patent Before Selling?
Authored by: Annie Sharma, Marketing Team
Data Expert: Jogeshwar Singh, Product-Development Team
